chromosome mediated by dosage compensation complex (DCC). Experimental studies 23 on the role of DCC on RNA polymerase II (Pol II) transcription in mammals disclosed 24 a non-linear relationship between Pol II densities at different transcription steps and 25 mRNA expression. An ~20-30% increase in Pol II densities corresponds to a rough 26 200% increase in mRNA expression and two-fold up-regulation. Here, using a simple 27 kinetic model of Pol II transcription calibrated by in vivo measured rate constants of 28 different transcription steps in mammalian cells, we demonstrate how this non-linearity 29 can be explained by multi-step transcriptional regulation. Moreover, we show how 30 multi-step enhancement of Pol II transcription can increase mRNA production while 31 leaving Pol II densities unaffected. Our theoretical analysis not only recapitulates 32 experimentally observed Pol II densities upon two-fold up-regulation but also points to 33 a limitation of inferences based on Pol II profiles from chromatin immunoprecipitation 34 sequencing (ChIP-seq) or global run-on assays.
Body

37
Unequal number of X chromosomes in males and females of several organisms 38 imposes a dosage problem on expression of X-linked genes. In the absence of a proper 39 regulatory mechanism, this imparity potentially leads to unequal expression of X-linked 40 genes and sex lethality. To overcome this challenge, a "dosage compensation" 41 mechanism is evolved to compensate the expression of X chromosomes [1] [2] [3] 
. In 42
Drosophila, the one copy of X-chromosome in males is roughly transcribed by two-43 fold to balance the expression of the two X chromosomes in females 4-7 . In mammals, 44 an X chromosome in females is primarily inactivated to balance the expression of X-45 linked genes with males 8-10 . Moreover, mammalian X chromosome is further hyper-46 transcribed in order to satisfy X-Autosome expression ratio 11,12 . 47 Recent studies in Drosophila and mammals using chromatin 48 immunoprecipitation and global-run-on sequencing (i.e., ChIP-seq and GRO-seq) have 49 addressed the interference of dosage compensation with Pol II transcription at different 50 steps. In mouse embryonic stem cells (ES cells), dosage compensation is shown to 51 increase Pol II densities at initiation (i.e., phosophorylated Pol II at Serine 5, i.e., Pol 52 II-S5P) without significant changes in the elongated form of Pol II (i.e., 53 phosophorylated Pol II at Serine 2 or Pol II-S2P) 13 . In another study of dosage 54 compensation in mouse female embryonic kidney fibroblasts, both Pol II-S5P and 55
PolII-S2P densities were found enhanced 12 . In Drosophila, whether dosage 56 compensation facilitates Pol II progression across active X-linked genes 14 or enhance 57 recruitment of Pol II to promoters 15 has been controversial [16] [17] [18] . 58
From the above-mentioned experimental studies, one emerging pattern is a non-59 linear relationship between Pol II densities at different steps of transcription and mRNA 60 expression levelError! Bookmark not defined.. In Drosophila, Pol II tag density 61 over the bodies of X-linked genes compared to autosomal genes is shown to differ by 62 a factor of ~1.4 14 with ~1.2 folds increase at promoters 17 . In the case of X chromosome 63 up-regulation in mammals, Pol II at promoters and along the body of active genes was 64 reported to be increased by ~1.3 and ~1.2 fold respectively 12 . In both examples, mRNA 65 levels are increased by ~two-fold upon hyper transcription. How does an ~30% increase 66 in Pol II density gives rises to ~200% increase in mRNA production? 67
Here, we justify this non-linear relationship based on multi-step regulation of 68 transcription machinery. Our assumption is that dosage compensation is achieved by 69
proper alterations of different steps of Pol II transcription. We use the following kinetic 70 framework for Pol II transcription ( Figure 1A (5) 76
Equations 1-5 describe dynamics of Pol II at different transcriptional steps (i.e, 77 in pre-initiation complex, P pic , at initiation, P ini , engaged to gene bodies, P eng , and as 78 free molecules, P free ) and mRNA molecules. In this framework, free Pol II molecules 79 bind to and unbound from promoters with the rate constants k on and k off and proceed to 80 initiation and elongation with the rate constants of k ini and k esc . In addition to 81 termination described by the rate constant k term , Pol II transcription is stopped by 82 abortive initiation with the rate constant k abor . We modeled mRNA production and 83 clearance by the term (+ (9 The ratios of Pol II abundances at different steps upon up-regulation (denoted 91 by an "Up" superscript) to the original system are written as: 92
From equations 9 to 11, any change in Pol II abundance is proportional to 96 mRNA fold change (i.e., in the case of P eng fold change). To calculate the left 98 sides of equations 9-11 and to check whether we can reckon the experimentally 99 observed increased Pol II density at promoters and along the gene bodies, we calculated 100 values of new rate constants assuming two-fold up-regulation. Theoretically, up-101 regulation can be modeled by one-step (i.e., changing one rate constant), two-step or 102 multi-step perturbation to the original transcription system defined by equations 1-5. 103
Once dosage compensation was achieved (i.e., [KLMN] :: qJ = 2 [KLMN] :: ), the new 104 rate constants were used to calculate the fold changes in Pol II density at different stages 105 of transcription using equations 9 to 11. We employed in vivo estimates of Pol II 106 transcription rate constants in mammalian cells (See Table S1 for parameters used in 107 the model) 19 and for simplicity assumed no change in mRNA export rate upon dosage 108 compensation (i.e., + 9IJ qJ = + 9IJ ). 109
Perturbing one transcription step to achieve two-fold mRNA production linearly 110 increases Pol II abundance in subsequent steps (See Table S2 ). For example, increasing 111 the rate of initiation (i.e., by increasing k ini ) results in increased densities of P ini , and 112 P eng . However, two-step perturbation of transcription machinery causes less than two-113 folds increase in abundance of Pol II at any step which its production and clearance rate 114 are increased simultaneously (See Table S3 and Figures S1-S10 for details). Figure 1B the figure, mRNA production is doubled by increasing initiation and promoter-escape 119 rate by ~1.2 to 2 folds, simultaneously. However, as shown in Figure 1C , P ini is clearly 120 enriched less than two fold when k ini and k esc are changed at the same time. Given the 121 original kinetic rate constants, ~30% increase in P ini corresponds to two-fold mRNA 122 production. A similar situation holds for P eng when k esc and k term are perturbed at the 123 same time ( Figures 1D and 1E ). An ~20% increase in Pol II abundance along the gene 124 bodies is associated with two-fold mRNA production. 125
Although perturbing initiation and promoter-escape rates gives rises to P ini fold 126 changes in agreement with experimentally observed values, P eng is increased by ~two-127 fold (See Table S3 for Pol II abundance at gene bodies while k ini and k esc are perturbed). 128
We thus checked a three-step perturbation analysis and found a combination of k ini , k esc 129 and k term that satisfies ~10% to 30% increase in P ini and gene bodies upon dosage 130 compensation (See Table S4 and S5 for details). 131
Next, we asked whether multi-step regulation of transcription can account for 132 two-fold mRNA expression while P ini is unaffected. In Figure 1F , red and blue 3D 133 curves show mRNA and P ini fold changes as functions of k ini and k esc . The intersection 134 of mRNA 3D curve with the plane at fold change=2 defines a 2D curve for dosage 135 compensation which is projected on k ini -k esc plane in Figure 1F . We also projected the 136 intersection of 3D P ini levels with the plane at fold change=1 in blue. These two curves 137 crossed each other at + 9:; qJ~2 + 9:; and + ,-, qJ~1 .2+ ,-, causing two-fold mRNA 138 production and insignificant changes in P ini levels. This condition corresponds to an 139 expected ChIP profile in Figure 1G which is most likely misinterpreted as no change in 140
Pol II densities at initiation and a significant change in Pol II densities at elongation 141 steps, although both steps have been enhanced (schema in Figure 1H ). In line with 142 previous studies on erroneous inferences from ChIP profiles 20 and inapplicability of 143
ChIP-seq and Gro-seq in study of Pol II turnover 21 , our study systematically shows the 144 limitation of these methods in addressing relevance of Pol II enrichment at different 145 transcription steps. 146
Taken these together, our theoretical approach suggests that Pol II transcription 147 is most likely regulated at multiple steps in dosage compensation. How is a multi-step 148 regulation modulated by DCC? There is compelling evidence that DCC proteins, 149 individually or in synergy, influence different transcription steps 22 . For example, in 150 mammals it is shown that MSL1 and MOF, two members of DCC complex, contribute 151 to enhanced densities of Pol II-S5P and therefore facilitates initiation 13 . In addition, 152
MOF as an acetyltransferase is responsible for H4K16ac, a histon modification which 153 decompacts nucleosomes and enhanced promoter-escape and transcriptional 154 elongation 14,18 . As we showed in this work, enhancing initiation, promoter-escape and 155 elongation rates suffice to explain the nonlinearity between Pol II levels and mRNA 156
expression. 157
The changes in kinetic constants are essential in reproducing the patterns of Pol 158 II transcriptional regulation as shown in this work. Two approaches can be used to 159 measure and compare kinetic rate constants. First, fluorescence recovery after 160 The correlations between the kinetic constants and POL-II abundance at different stages of transcription are shown in Table S5 .
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Parameter
Figure S1. mRNA fold change as a function of varying k ini and k esc from one-tenth to two-fold of their original values (i.e., k ini =0.0216 s -1 and kesc=0.00159 s -1 ).
Figure S2
. P prom fold change as a function of varying k ini and k esc from one-tenth to two-fold of their original values (i.e., k ini =0.0216 s -1 and kesc=0.00159 s -1 ).
Figure S3
. P ini fold change as a function of varying k ini and k esc from one-tenth to two-fold of their original values (i.e., k ini =0.0216 s -1 and kesc=0.00159 s -1 ).
Figure S4
. P eng fold change as a function of varying k ini and k esc from one-tenth to two-fold of their original values (i.e., k ini =0.0216 s -1 and kesc=0.00159 s -1 ).
Figure S5
. mRNA fold change as a function of varying k on and k off from one-tenth to two-fold of their original values (i.e., k on =0.0216 s -1 and k off =0.00159 s -1 ).
. P prom fold change as a function of varying k on and k off from one-tenth to two-fold of their original values (i.e., k on =0.0216 s -1 and k off =0.00159 s -1 ).
Figure S6
. P ini fold change as a function of varying k on and k off from one-tenth to two-fold of their original values (i.e., k on =0.0216 s -1 and k off =0.00159 s -1 ).
. P eng fold change as a function of varying k on and k off from one-tenth to two-fold of their original values (i.e., k on =0.0216 s -1 and k off =0.00159 s -1 ).
Figure S7
. mRNA fold change as a function of varying k abor and k term from one-tenth to two-fold of their original values (i.e., k abor =0.0170 s -1 and k term =0.0016 s -1 ).
Figure S8.
. P prom fold change as a function of varying k abor and k term from one-tenth to two-fold of their original values (i.e., k abor =0.0170 s -1 and k term =0.0016 s -1 ).
Figure S9
. P ini fold change as a function of varying k abor and k term from one-tenth to two-fold of their original values (i.e., k abor =0.0170 s -1 and k term =0.0016 s -1 ).
Figure S10.
. P eng fold change as a function of varying k abor and k term from one-tenth to two-fold of their original values (i.e., k abor =0.0170 s -1 and k term =0.0016 s -1 ).
